Member Info for JustHereForHemo

We could talk about the website!!! :-D
But yes it was a pointless argument, I dont care who started it, the potential here is too big to waste our time debating a day of the week :P
Peace, I have nothing against you I have spoke to HFH and he also just enjoys a bit of drama to fill the time :-)

I think we can all agree that the update was lacking in detail but full of promise, as has been pointed out its a legal document and it has been approved by auditors so we can trust it. The number one question for me right now is CBR..... What is going on in the bio defence side? Has Vlad applied for grants? Has he been speaking to anyone from the government? How did he get an invite to that meeting? Lets face it we know next to nothing about what they are doing with CBR, its all CAR-T so updates would be very much appreciated Vlad!!!

People in glass houses.... Pretty sure HFH and myself both said something similar (I really cba to check) that it COULD come earlier than tomorrow. Honestly the whole problem with you is that you stated as a fact, multiple times with absolute certainly that the Interim Results would be released on the 30th. Fact was everyone agreed they probably would but everyone else on this board knew that it was still possible they would be early. Same for Vlad not recording the webinair when you doubled down on it not being recorded. If you had just said probably 30th, probably not recorded then nobody is going to say anything because you would probably have been right. But go ahead and divert and distract if you wish :P

Pumpkin, unlike others I am not here to "break even" or even "bag" ;-)
I get that many have lost faith in Vlad or are frustrated, I get it, I am too, but my confidence is through the roof these days.
The video of Vlad being at what surely was an invite only Biodefence meeting sent shivers through me.....

I question why some are invested here if all they can look for is the negatives....
Todays update is good, positive progress, plenty of cash, great holding RNS giving confidence to current holders. For those looking to trade, those who want to buy and hold for the bare minimum amount of time before dumping on news this was not a good update as it did not give away that level of detail, so news could be days, weeks, months.

You buy and hold a share because you believe its worth and will be worth more than its current value, so WHAT do you value Hemogenyx at HT? I honestly cannot get my head around the self destructive posting of so called shareholders attacking a share they hold. We all have our occasional moan but for some its non stop.
I hold shares here because I value CAR-T at 500m+ in a few months time, CBR.... (alot more), and CDX somewhere in the middle. I value Hemogenyx today against its peers as worth at least £150m which is a significant upside from where it is right now. If I didnt think it was worth even a fraction of that or that it would not move up in the short term why on earth would I hold? So perhaps I am giving too much credit when I assume other shareholders do some sort of similar calculations when deciding what to buy?
There is so much potential news flow which could shift our SP north that its just such an obvious hold to me that I cannot grasp this constant negativity, the only justification I can think of its coming from people who are not currently holders, are balls deep elsewhere and feel entitled to get in here before news lands and are just negative trying to convince themselves and others they have time.

Even in this dire environment where it looks like the end of worlds Hemo should be WAYYY north of 50m, this SP is a joke, it wont last. This close to trials, this many potential inflection points, this much IP and the reassurance they are funded? Bonkers, absolute bonkers. And yet we get arguments about websites......
At some point either one of these Biodefense contacts will start talking about Hemo, or Vlad will secure a grant, or he will sign a licencing deal or partnership, or he will file an IND. Which is going to be first? No idea! But one of those is going to happen, none of them have happened for the past 3 years despite getting ever and ever closer and more and more likely, you cannot flip a coin and keep landing on tails, at some point its going to land heads up for holders. When that happens the trolls will disappear and these pathetic stupid prices will be long forgotten.

In Vlad We Trust!

And another pumpkin 135k. Almost certainly its Tahir: https://twitter.com/Tahirme61523728
Posted just after the buys and now deleted his posts about hemo. Quality pump and dumper from Telegram groups ;-D

Spot on MrIndia, somewhat underwhelming in terms of details. HOWEVER, in this current market it was reassuring and positive, its all about the money and this is key for me:
"On track and on budget for initiating phase I clinical trials of HEMO-CAR-T"

"The Company is exploring partnership options for taking CDX through final IND-enabling studies and into clinical trials." - This was alluded to in the last webinar (Which was recorded and made available...), the company clearly are speaking to people and have options but again holding everything close to their chest.

CBR - "completed preparations to test it against live replicating virus" + "biodefence platform" (Thanks HFH), if I am being totally honest I am disappointed by the progress, I had expected it to be tested against a live virus by now. However the company focus is on getting CAR-T to clinical ASAP and its pharma which is slow so it comes with the industry. I am glad to see the highlight to biodefense, nothing has been said officially however Vlad has attended what I can only assume was an invite only biodefence conference, he has made it clear they were seeing non dilutive funding and grants etc.... There is no smoke without fire, just Vlad is keeping extremely quiet, but seriously, Vlad is meeting people like Rajesh Panjabi – Special Assistant to the President and Senior Director for Global Health Security & Biodefense and Dr. Anthony Fauci....

Cash - £5.8m with burndown rate of £2.6m pa - Extremely reassuring, in this market most shares are struggling and many still need to raise, dilution destroys small cap investors. The fact that Vlad has the money, does not need to raise and is extremely frugal is why I am willing to just wait.

Overall - Great update for investors looking reassurance, nothing in there that can be highlighted as negative and plenty to look forward too. As an existing shareholder I have confidence things are progressing and they remain fully funded, as a potential investment for others IMO the potential here is huge with acceptable risk.
This update appears crafted deliberately to deny traders. It calls out the potential and makes it clear how undervalued it is whilst providing no specifics, the next significant update could come in a day, a week or a month, vlad has given nothing away.

I dont believe these low prices are sustainable, I believe anyone trading is just gambling and at some point you will be locked out. There is an argument that Pharma is high risk and small caps are notorious for dilution. Well here the transformative point will likely be IND or some sort of grant, both of which come before any high risk clinical results, and as for dilution, its there in black and white, they are on budget and funded.

Have a great weekend, it is Friday afterall! :-)

Suspension is not always bad....
TMOR is one of my suspensions, its very positive
LIFE is the other.... its not positive, company is a sht show, got fined by AQUIS, BoD crooks, HOWEVER because its been suspended the SP has not tanked and they have not done any more placings and are forced to get their sht together before they are allowed to trade again so the suspension is positive.

In fairness 2 of mine are also suspended.....

Nope, I have zero interest in trading Hemo, I hold and I add. Glad you got out of CINE, I just cannot see how it does not tank further but who knows in this market(10% up atm, so go figure). My sympathies to those forced to sell, I know one of todays sellers who just has a bill to pay. I am not looking forward to the coming increases in my own mortgage, times are getting difficult and with this government I am not sure I have faith things will get better any time soon.
Looking forward to the interim results, should be something positive in an otherwise bleak few weeks and months. Be nice if they came tomorrow, not a fan of good news on a Friday.

I think there is more chance of getting 1p in CINE, how is that trade going?

Same... seemed obvious that the 30th was not a friday every year but in this day and age you have to spell everything out...
Also HT, just to be clear, there is every chance they will come out on Friday, HOWEVER, they do not HAVE to be Friday, Vlad can if he wishes release them right now, or tomorrow or Thursday.
They HAVE to:
"The half-yearly financial report must be made public as soon as possible, but no later than three months, after the end of the period to which the report relates."
So they can come any time between:
30 June 2022 up to and including 30th September 2022...
There is absolutely no rule or regulation or even internal Hemogenyx policy that says they MUST be the last Friday of September. They have a 3 month window (Technically there are exemptions and waivers they can use to be late if necessary)

WHAT A POINTLESS STUPID ARGUMENT... Seriously though arguing about when it will come out is so pathetic compared to discussion about what is in it. I really dont want to waste the breath on this argument about what day its out which is below every one of us, does it really matter? You will probably end up being right and it very likely could be Friday, just stop stating it like its a fact and MUST be Friday because that just triggers my OCD.

Last year they came out on a Thursday...
2020 it was a Wednesday...

Well played sir. Well played.....

HT, I love how you state facts which are just assumptions, same as how the webinar would not be recorded and made public :P Dont get me wrong, every chance its Friday given it was 30th last few years, but hardly set in stone, could easily come before.

You can lead a horse to water but you can't make him drink

I love a good argument :-P
HFH I disagree with your valuations personally, CDX IMO is worth a lot more than 500k ;-D I am going to assume that is a typo :P
That said even if you mean 500m, IMO that is more where I value CAR-T with its more limited patient pool. CDX does not get much mention these days but its worth remembering that per the patient that was granted it works on ALOT of targets, its a substitute for Chemo+radio therapy for Cancers, for Lupus and other autoimmune disease. Basically any condition that requires a bone marrow transplant to cure. The market is massive for an off the shelf CDX which would be cheaper than CAR-T.
Anyway, lets see what the report brings, hopefully it comes early, tomorrow or thursday ideally, if not Friday morning please Vlad :P
If it shows progress and even a sniff they are applying for grants....... £12mil mCap? Dont make me laugh!!!

All good, and understood micky :-)
Digit, stick on your wellies and wade back in, Q4 starts in a few days ;-) I am not expecting any huge news which of itself would warrant a standalone RNS.
I agree any award of a large grant etc should be separate but aside from that I am sure there are many incremental updates which vlad has decreed not worthy of an RNS on its own but which collectively will show progress in the past 6 months. Its touching October, we are into the CAR-T IND window so it could be days/weeks/months, and unless anyone has spoken to Vlad none of us know how far along this is. Those conference calls and meetings that Vlad held with investors earlier in the year made it clear that someone was testing CBR, someone was testing CDX and the company was looking at non-dilutive funding which squares with his recent attendance at the Biodefense commission.
If there is nothing significant until Q1 so be it, I have no big plans to add many more shares so its just a waiting game. But for those on the side lines actively waiting for end of Q4 or Q1 IMO its a huge gamble, only needs one significant update to shift this annoyingly sticky sp.

Micky, a little uncalled for and Digitt I think your also being unfair.
No inside knowledge required, just common sense and MrIndia this time is correct:
https://www.handbook.fca.org.uk/handbook/DTR/4/2.html
Every year since Silver Falcon became Hemo there has been a half year update on or before 30th September which is this week. Certainly not guaranteed but extremely likely.
Its possible to go back and look at previous year updates and see what sort of content can be expected and its usually pretty good with updates that are new to the market. I fully expect an update on CAR-T, CBR and CDX, in particular with CDX I would expect it to positively confirm progress eg with Master Cell line which many of us thought warranted its own RNS. So if we believe it deserved an RNS and this is confirmed in THIS update then surely this update can be classified as "Positive news?"
Previous updates have also made clear the cash position and fundraising efforts, which if this time highlights significant cash reserves + potentially application for dilution free grants etc then that would be again "Positive news"
Then there is CBR, last update was start of the year, some/many making assumptions it has been put on back of the shelf because of the lack of updates. However this update should make it clear that is not the case, which again would be "positive news"
I understand the urge to have a go at MrIndia, well... Just because its MrIndia... But 2 wrongs does not make a right.

What will the update do for the SP? Who knows. We dont know whats in it yet. Maybe those with the negative posts will be proven right and nothing is happening.
But maybe CAR-T is well ahead in the manufacturing runs with IND approaching fast.
Maybe CDX Master cell line is complete and available and now with third parties for testing
Maybe CBR has sparked alot of interest and we will find out shortly who the third party is
Maybe Hemogenyx has applied for and are expected to receive grants.
Any one of the above would be significant and make our £12mil mCap look a complete joke. I have no idea what will be in the update, but given we are already around all time lows I see much better value in holding to see what happens vs gambling that nothing positive comes.

Well... he says he was there and then there us that video that runs for like 5 hrs, most of the time you can only see his shoes but you do get glimpses of his face... So there is that I guess...... I also never said he spent hours talking to them so please dont take my words out of context. I said he and they were there for hours in the same room, its very unlikely they never talked for all that time.
Please note the ENTIRE 5+ hours of video has been uploaded, breaks and intermissions and all. So yea. Thats my proof, believe it or dont, I really dont care.

No worries Chris :-) and HT, your comment is just unnecessary. He was there, he was sitting a few meters away from Dr Fauci et all for several hours. He never said he presented or was being featured, but I for one didn't get an invite in the post how about you.... He spent HOURS there with Special Assistant to the President and Senior Director for Global Health Security & Biodefense, National Security Council, The White House.
I am not saying that President Biden is about to land up at Mink Building with a cheque for 1 Gazillion dollars for Hemogenyx. But it should be perfectly clear to everyone that Dr Sandler is NOT rubbing shoulders with these people to discuss CAR-T or the company T-Shirts. He is there because the very definition of CBR is Bio defence against the very threats that they are talking about. The US government has made it clear they want to support academia, big pharma and small pharma who are working towards detecting, preventing and treating future pandemics.
IF CBR was on a back shelf in storage room 2b waiting for a few years then Vlad would not be attending these conferences. The attendance also appeared quite small, chances of Vlad NOT mingling and chatting whilst he was there?...

Many, (many of whom like to message me privately frequently), are down/pessimistic/negative about Hemogenyx because of the "lack of updates" and "Share Price". Lets highlight something that should be really obvious to everyone, but clearly its not. The efficacy and safety profile of CAR-T, CDX and CBR are NOT AFFECTED BY SHARE PRICE. The FDA do not look at the Share Price when deciding to apply clinical holds or not, nor do the people at that Conference care about the share price.

Vlad is clearly convinced CBR works and is looking to progress it quickly, if people chose to look at the recent tweets and assume its smoke and mirrors and CBR is nothing then please sell and move on its just pathetic. If however it is as good as has been represented then it will be HUGE.

Many also like to represent that there is "Nothing until Jan 2023" again basing this on nothing more than their interpretation of the slides and the fact Vlad has been quiet.... Well its not like Vlad is sitting on a beach drinking beer. Mistake 1, Assuming that a timing "Window" is a time "Line".
Mistake 2, Assuming that Vlad is going to keep us updated on progress unless absolutely necessary.

I will continue to add and hold as others sell and wait expecting to buy in later, at some point it will be too late and I look forward to that time. This share price is unrealistic and unsustainable, at some point either Hemogenyx will be noticed and make it to the papers or they will file IND or they will get a large grant or sign a partner. Games are being played right now, genuine LTH'ers, to you all I can say is I am more excited now than I have been for the past 4 years.

#InVladWeTrust